Global  

Purdue reaches tentative opioid settlement -sources

Video Credit: Reuters Studio - Duration: 00:45s - Published
Purdue reaches tentative opioid settlement -sources

Purdue reaches tentative opioid settlement -sources

OxyContin maker Purdue Pharma reached a tentative agreement with some plaintiffs to resolve widespread litigation over its alleged role in fueling the U.S. opioid crisis and plans to tussle with states opposing its settlement offer in bankruptcy proceedings starting as soon as next week, people familiar with the matter said.

Jillian Kitchener reports.

Purdue Pharma - the maker of OxyContin - has reached a tentative settlement valued at up to 12 billion dollars to resolve widespread litigation over its alleged role in fueling the American opioid crisis.

That's according to people familiar with the matter, who told Reuters on Wednesday that Purdue also plans to battle it out with the plaintiffs that oppose its settlement offer in bankruptcy court... starting as soon as next week.

Some states and the Sackler family appear to be stuck over how much of the family’s personal fortune will be paid out to plaintiffs.

The lawsuits claim the family and company contributed to a public health crisis that resulted in nearly 400,000 deaths.

Purdue and the Sacklers have denied the allegations.




You Might Like


💡 One News Page Knowledge: Other News Mentions

Purdue University Purdue University Public research university in West Lafayette, Indiana, United States

Purdue Pharma settlement marks second guilty plea for company

The plea bargain does not foreclose future criminal charges against the Sackler family owners and Purdue's executives. 60 Minutes has covered the opioid epidemic..
CBS News

What scientists hope to learn from a beetle that can survive being run over by a car

It’s a beetle that can withstand bird pecks, animal stomps and even being rolled over by a Toyota Camry. Now scientists are studying what the bug’s..
WorldNews

Purdue Pharma Purdue Pharma American pharmaceutical company

OxyContin Maker Purdue Pharma to Plead Guilty to 3 Federal Charges [Video]

OxyContin Maker Purdue Pharma to Plead Guilty to 3 Federal Charges

Justice Department officials made the announcement on Wednesday.

Credit: Cover Video STUDIO    Duration: 01:19Published

AP Top Stories Oct. 21 P

Here are the top stories for Wednesday, Oct 21st: Trump and Biden campaigns make October sprint; Justice Dept. announces Purdue Pharma settlement; Barrett visits..
USATODAY.com

Opioid crisis: OxyContin maker Purdue Pharma to plead to 3 criminal charges

Drugmaker Purdue Pharma, the company behind the powerful prescription painkiller OxyContin that experts say helped touch off an opioid epidemic, will plead..
New Zealand Herald
OxyContin maker to plead guilty in opioid probe [Video]

OxyContin maker to plead guilty in opioid probe

Purdue Pharma agreed to plead guilty to criminal charges over the handling of its addictive prescription opioid OxyContin, in a deal that comes with a $8.4 billion settlement but stops short of criminally charging its executives or wealthy Sackler family owners. Conway G. Gittens has more.

Credit: Reuters Studio    Duration: 02:37Published

Oxycodone Oxycodone Opioid medication


Raymond Sackler

Purdue Pharma Pleads Guilty to Criminal Charges for Opioid Sales

The Justice Department announced an $8 billion settlement with the company. Members of the Sackler family will pay $225 million in civil penalties but criminal..
NYTimes.com

OxyContin maker reportedly to plead guilty to 3 criminal charges

The deal does not release any of the company's executives or owners – members of the wealthy Sackler family – from criminal liability, the Associated Press..
CBS News
OxyContin maker nears guilty plea in opioid probe [Video]

OxyContin maker nears guilty plea in opioid probe

[NFA] Purdue Pharma, the OxyContin maker controlled by members of the wealthy Sackler family, is nearing an agreement to plead guilty to criminal charges as part of a broader deal to resolve U.S. Justice Department probes into its alleged role in fueling the nation’s opioid crisis, several sources told Reuters exclusively. Conway G. Gittens has the details.

Credit: Reuters - Politics    Duration: 00:24Published

Related news from verified sources

Purdue Pharma reaches tentative opioid settlement with some: sources

OxyContin maker Purdue Pharma LP reached a tentative agreement with some plaintiffs to resolve...
Reuters - Published Also reported by •Reuters IndiaDenver Post


What's ahead after the Purdue tentative settlement

CLEVELAND (AP) — Wednesday's tentative $12 billion settlement by some state, local and tribal...
SeattlePI.com - Published Also reported by •Seattle Times


AP EXPLAINS: The tentative Purdue deal on the opioid crisis

COLUMBUS, Ohio (AP) — A deal worth as much as $12 billion that's being negotiated between Purdue...
SeattlePI.com - Published


Tweets about this


Related videos from verified sources

Purdue Pharma's Bankruptcy Move Draws Criticism Amid Ongoing Opioid Epidemic [Video]

Purdue Pharma's Bankruptcy Move Draws Criticism Amid Ongoing Opioid Epidemic

Purdue Pharma, the company behind the prescription painkiller OxyContin, has filed for bankruptcy. The filing comes days after it reached a settlement with more than 20 states which blame Purdue for..

Credit: CBS 2 New York     Duration: 02:20Published
Purdue Pharma Files for Bankruptcy [Video]

Purdue Pharma Files for Bankruptcy

Purdue Pharma Files for Bankruptcy . The maker of OxyContin filed for Chapter 11 bankruptcy protection on Sunday. . A tentative settlement was made last week with more than 2,000 local..

Credit: Wibbitz Top Stories     Duration: 01:43Published
Oxycontin Maker Purdue Pharma Declares Bankruptcy After Opioid Crisis Settlement [Video]

Oxycontin Maker Purdue Pharma Declares Bankruptcy After Opioid Crisis Settlement

According to Purdue Pharma, the bankruptcy is worth $10 billion and will go toward addressing the opioid crisis in New York, New Jersey and elsewhere around the country. CBSN New York's Aundrea..

Credit: CBS 2 New York     Duration: 02:33Published